D-0696-2026 Class II Ongoing
FDA drug recall D-0696-2026 was initiated by Blaine Labs Inc on April 8, 2026 and is designated Class II. Reason for recall: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry The recall status is ongoing. Affected quantity: 26,475 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- July 8, 2026
- Initiation Date
- April 8, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 26,475 bottles
Product Description
vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, UPC 6 16728 00039 2.
Reason for Recall
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Distribution Pattern
Nationwide in the USA
Code Information
Lot BL3462, Exp. 2/7/2027